Trials / Recruiting
RecruitingNCT05258292
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes: the GLYMETY Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 86 (estimated)
- Sponsor
- Institut de Recherches Cliniques de Montreal · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
In clinical practice, women living with type 1 diabetes frequently report that insulin requirements change across the menstrual cycle. Consequently, glycemic fluctuations are observed. This phenomenon could be explained by a decrease in insulin sensitivity during the second half of the menstrual cycle (luteal phase). Overall, despite an important proportion of women reporting glycemic and/or insulin variations across the menstrual cycle, studies to date have involved small sample sizes, and have had inconsistent results. The objective of this study will be to study glycemic fluctuations across the menstrual cycle using CGM data, alongside insulin data, in a large sample of women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous glucose monitoring | Glucose levels will be measured using continuous glucose monitoring |
| DRUG | Insulin | Insulin doses will be retrieved from insulin pump reports (for insulin pump users) or journals for (for multiple daily injections users) |
| OTHER | Premenstrual symptoms | Premenstrual symptoms will be assessed using the Premenstrual symptoms screening tool |
| OTHER | Ovulation kits | Ovulation testing will be done using ovulation kits |
| DEVICE | Fitbit Inspire 2 | Physical activity will be assessed using the Fitbit Inspire 2 |
| OTHER | Keenoa | Food intake will be assessed using the Keenoa phone application |
| OTHER | Menstrual cycle | The application My Calendar will be used to record information on the menstrual cycle |
Timeline
- Start date
- 2022-05-02
- Primary completion
- 2026-04-01
- Completion
- 2026-05-31
- First posted
- 2022-02-28
- Last updated
- 2026-03-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05258292. Inclusion in this directory is not an endorsement.